Novel human lipocalin homologs and polynucleotides encoding the same

• US 20050048537A1
• Filed: 06/14/2004
• Published: 03/03/2005
• Est. Priority Date: 05/12/2000
• Status: Abandoned Application

• Current Assignee: Brian Mathur, Turner C. Alexander Jr
• Original Assignee: Brian Mathur, Turner C. Alexander Jr
• Inventors: Mathur, Brian, Turner, C. Alexander Jr.
• Application Number:
  US10/867,284
• Publication Number:
  US 20050048537A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: A61P 21/00 Drugs for disorders of the muscular or neuromuscular system
• CPC Class Codes: A61P 25/00 Drugs for disorders of the nervous system
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: A61P 7/02 Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
• CPC Class Codes: C07K 14/47 from mammals

Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

Claims

1. An isolated nucleic acid molecule comprises at a nucleotide sequence encoding an amino acid sequence drawn from the group consisting of SEQ ID NOS:

2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, and 28.

2. (cancelled)

3. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes the amino acid sequence shown in SEQ ID NO:

2.

5. The isolated nucleic acid molecule of claim 3 wherein said nucleotide sequence is that of SEQ ID NO:

1.

4. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes the amino acid sequence shown in SEQ ID NO:

18.